TrialBMC psychiatry2022

Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.

Sanaz Askari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.